Gowan Company Announces Acquisition of Ceradis

Gowan Company announced the acquisition of Ceradis. The deal strengthens Gowan's presence in Europe and the Americas, while also expanding its research portfolio.

Ceradis, headquartered in Wageningen, the Netherlands, offers unique technologies based on biomineral solutions. These technologies integrate disease management programs by combining conventional pesticides with natural compounds, promoting the durability of active ingredients and meeting sustainability requirements.

According to Rob Plaice, Gowan's global director of research and development, the acquisition reinforces the company's long-term strategy of uniting science and innovation for sustainable agriculture. Ceradis' multi-action products help maintain pesticide efficacy and expand the range of alternatives available to farmers.

Willem-Jan Meulemeesters, CEO of Ceradis, emphasized that the merger expands the global reach of biological technologies and encourages the adoption of more sustainable agricultural practices. The transaction ensures continuity for customers, creates opportunities for employees, and reaffirms the company's commitment to food safety and regulatory standards.

Ceradis will continue to operate from its headquarters, now integrated into Gowan's global network.